IPP Bureau
Zorvia opposes adjournment in defamation case against Emcure, Zuventus before Thane Court
By IPP Bureau - April 20, 2026
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
UICC report flags air pollution as major multi-cancer risk
By IPP Bureau - April 20, 2026
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
C-CAMP hosts first National Diagnostics Conclave, unveils key reports and tools
By IPP Bureau - April 20, 2026
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
By IPP Bureau - April 20, 2026
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
By IPP Bureau - April 20, 2026
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
By IPP Bureau - April 20, 2026
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
AWS unveils Amazon Bio Discovery to accelerate drug design with AI
By IPP Bureau - April 20, 2026
FDA pushes forward on gene-editing therapies with new safety roadmap
By IPP Bureau - April 20, 2026
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Precision BioSciences expands Hepatitis B gene editing trial into France and Romania
By IPP Bureau - April 20, 2026
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Galderma rolls out next-generation regenerating skin nectar
By IPP Bureau - April 20, 2026
Philips wins FDA nod for AI-powered spectral CT system Verida
By IPP Bureau - April 20, 2026
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
Merck bags EU nod for infant RSV protection in major public health milestone
By IPP Bureau - April 19, 2026
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Takara Bio and Resistomap forge deal to speed up global fight against superbugs
By IPP Bureau - April 19, 2026
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
